Frequently asked questions and considerations for the introduction of hexavalent vaccine DTwP-HepB-Hib-IPV in routine immunization programmes (June 2024)

This document is targeted primarily to countries currently using pentavalent and inactivated polio vaccine
(IPV) schedules. This information is also applicable to countries planning to switch from acellular pertussis
combination vaccines to the newly prequalified DTwP-HepB-Hib-IPV hexavalent vaccine